Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

Share Price is delayed by 15 minutes
Get Live Data
454.00    24.00 (5.58%)
Bid:
452.00
Ask:
453.00
Spread: 1.00 (0.221%)
Market Cap: £1.24b
CMCX Live PriceLast checked at - London Stock Exchange

Intraday CMC Markets Share Chart

ESMA Announcement

27 Mar 2018 10:30

RNS Number : 0685J
CMC Markets Plc
27 March 2018
 

27 March 2018

 

 

CMC Markets Plc

 

ESMA Announcement

 

 

CMC Markets Plc ("CMC") notes the announcement by the European Securities and Markets Authority (ESMA) issued today.

ESMA's announcement introduces temporary product intervention measures on the provision of contracts for difference (CFDs) and binary options to retail investors. The measures announced today are largely unchanged from those proposed by ESMA in December 2017. The FCA expects to consult on whether to apply these measures on a permanent basis. The measures introduced include the following:-

1. A prohibition on the marketing, distribution or sale of binary options to retail clients; and

2. Restrictions on the marketing, distribution or sale to retail clients of CFDs, including rolling spot forex and financial spread bets as follows:

 

- leverage limits on the opening of a CFD position by a retail client between 30:1 and 2:1, depending on the volatility of the underlying asset;

- a standard margin close-out rule on a per-account basis;

- negative balance protection on a per account basis;

- a prohibition on firms offering monetary and non-monetary benefits to retail investors; and

- a standardised risk warning, including firm-specific figures on the percentage of clients that have lost money trading CFDs.

 

CMC is well prepared for these measures and through its proprietary technology, will ensure that they are implemented as required. Fair client outcomes have always been a focus of the Group, with account level margin close-out and standard risk warnings already in place throughout the Group, as well as negative balance protection being offered in certain countries.

Binary products generated £2.1m of revenues from the UK and Europe in H1 18 and therefore any reduction in revenue will be immaterial in a Group context.

Margin changes are likely to have an impact on how clients trade, although at this stage it is not possible to quantify the impact. However, CMC remains confident that its strategy of targeting high value, experienced clients that could be categorised as 'elective professionals', puts it in a strong position to manage regulatory change.

 

Enquiries

CMC Markets Plc +44 (0) 20 7170 8200

Grant Foley, Chief Operating and Financial Officer

 

Camarco +44 (0) 20 3757 4984

Geoffrey Pelham-Lane

Ed Gascoigne-Pees

Jennifer Renwick

 

 

 

 

 

 

Notes to Editors

CMC Markets plc ("CMC"), whose shares are listed on the London Stock Exchange under the ticker CMCX (LEI: 213800VB75KAZBFH5U07), was established in 1989 and is now one of the world's leading online financial trading businesses. The company serves retail and institutional clients through regulated offices and branches in 14 countries, with a significant presence in the UK, Australia, Germany and Singapore. CMC Markets offers an award-winning, online and mobile trading platform, enabling clients to trade up to 10,000 financial instruments across shares, indices, foreign currencies, commodities and treasuries through contracts for difference ("CFDs"), financial spread bets (in the UK and Ireland only) and, in Australia, access stockbroking services. More information is available at http://www.cmcmarkets.com/group/

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFKODBCBKKFNB
Date   Source Headline
4th Jun 20267:05 amRNSDirectorate change
4th Jun 20267:00 amRNSPreliminary Results
6th May 20264:45 pmRNSDirector/PDMR Shareholding
8th Apr 20263:49 pmRNSDirector/PDMR Shareholding
24th Mar 202610:00 amRNSDirectorate change
6th Mar 20263:54 pmRNSDirector/PDMR Shareholding
6th Feb 20263:57 pmRNSDirector/PDMR Shareholding
12th Jan 202612:16 pmRNSDirector/PDMR Shareholding
6th Jan 20261:38 pmRNSDirector/PDMR Shareholding
8th Dec 20252:22 pmRNSDirector/PDMR Shareholding
20th Nov 20257:10 amRNSDividend Declaration
20th Nov 20257:00 amRNSInterim Results
6th Nov 20254:55 pmRNSDirector/PDMR Shareholding
3rd Nov 20251:30 pmRNSDirectorate change
7th Oct 20254:02 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSWestpac and CMC Extend Strategic Relationship
11th Sep 20259:40 amRNSDirector/PDMR Shareholding
8th Sep 202511:50 amRNSDirector/PDMR Shareholding
5th Sep 202512:14 pmRNSAppointment of Senior Independent Director
19th Aug 20254:22 pmRNSDirector/PDMR Shareholding
19th Aug 20254:20 pmRNSDirector/PDMR Shareholding
7th Aug 20253:59 pmRNSHolding(s) in Company
6th Aug 20254:08 pmRNSDirector/PDMR Shareholding
4th Aug 20251:23 pmRNSDirector/PDMR Shareholding
31st Jul 20253:53 pmRNSDirector/PDMR Shareholding
24th Jul 20251:21 pmRNSResult of AGM
23rd Jul 20255:20 pmRNSDirector/PDMR Shareholding
18th Jul 20252:36 pmRNSDirector/PDMR Shareholding
16th Jul 20254:57 pmRNSDirector/PDMR Shareholding
8th Jul 20253:04 pmRNSDirector/PDMR Shareholding
20th Jun 20255:11 pmRNSNotice of AGM
19th Jun 20254:53 pmRNSDirector/PDMR Shareholding
18th Jun 202512:18 pmRNSDirector/PDMR Shareholding
12th Jun 20259:45 amRNSConfirmation of Dividend Details
6th Jun 20254:07 pmRNSDirector/PDMR Shareholding
5th Jun 202512:48 pmRNSAnnual Financial Report
5th Jun 20257:30 amRNSDividend Declaration
5th Jun 20257:05 amRNSBoard and Directorate Changes
5th Jun 20257:00 amRNSFinal Results
7th May 20253:35 pmRNSDirector/PDMR Shareholding
8th Apr 20252:10 pmRNSDirector/PDMR Shareholding
7th Mar 20254:48 pmRNSDirector/PDMR Shareholding
6th Mar 202512:21 pmRNSDirector/PDMR Shareholding
27th Feb 20253:25 pmRNSDirector/PDMR Shareholding
25th Feb 20257:00 amRNSDirectorate Change
6th Feb 20253:01 pmRNSDirector/PDMR Shareholding
23rd Jan 20257:00 amRNSTrading Update
13th Jan 202510:08 amRNSDirector/PDMR Shareholding
6th Jan 20254:24 pmRNSDirector/PDMR Shareholding
6th Dec 202411:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.